Ocular Therapeutix Stock Price

-0.96 (-7.77%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ocular Therapeutix Inc OCUL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.96 -7.77% 11.39 13:10:09
Open Price Low Price High Price Close Price Prev Close
12.22 11.29 12.22 12.35
Bid Price Ask Price Spread News
11.38 11.40 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,644 713,060 $ 11.73 $ 8,365,360 - 7.14 - 24.30
Last Trade Time Type Quantity Stock Price Currency
13:10:09 100 $ 11.39 USD


Draw Mode:

Ocular Therapeutix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 868.97M 76.29M 68.38M $ 17.40M $ - -2.60 -5.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 126.00k 2.10%

more financials information »

Ocular Therapeutix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OCUL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.9113.4911.2912.38831,864-0.52-4.37%
1 Month14.1514.7311.2913.08758,033-2.76-19.51%
3 Months18.3518.602711.2914.41930,019-6.96-37.93%
6 Months21.0021.4811.2916.641,022,675-9.61-45.76%
1 Year8.7324.307.1415.121,046,3022.6630.47%
3 Years5.7524.302.359.51802,6985.6498.09%
5 Years4.4324.302.358.73787,6526.96157.11%

Ocular Therapeutix Description

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application.

Your Recent History
Ocular The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.